日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Older Versus Younger Patients

比较老年患者与年轻患者接受单倍体相合外周血干细胞移植后使用环磷酰胺的疗效

Adoncecchi, Giacomo; Kumar, Ambuj; Mogili, Krishnakar; Faramand, Rawan; Liu, Hien; Khimani, Farhad; Mishra, Asmita; Nieder, Michael; Nishihori, Taiga; Hansen, Doris; Jain, Michael; Lazaryan, Aleksandr; Perez, Lia; Pidala, Joseph; Locke, Frederick; Anasetti, Claudio; Bejanyan, Nelli; Elmariah, Hany

JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results

尽管Th1/Th17细胞减少,JAK2/mTOR抑制剂仍未能预防急性GVHD:2期临床试验最终结果

Pidala, Joseph; Holtan, Shernan G; Walton, Kelly; Kim, Jongphil; Cao, Biwei; Elmariah, Hany; Mishra, Asmita; Bejanyan, Nelli; Nishihori, Taiga; Khimani, Farhad; Perez, Lia; Faramand, Rawan G; Davila, Marco L; McSain, Shannon; Pleskow, Jordan; Baron, Jeffrey; Anasetti, Claudio; Moran Segura, Carlos; Weisdorf, Daniel J; Blazar, Bruce R; Miller, Jeffrey S; Bachanova, Veronika; El Jurdi, Najla; Betts, Brian C

Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-versus-host disease

通过微调针对HLA-DP的同种异体反应来控制白血病,并实现可耐受的移植物抗宿主病。

Pidala, Joseph; Anasetti, Claudio

Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial

使用移植后环磷酰胺治疗不匹配无关供者骨髓移植患者的三年预后:一项由国家骨髓捐献者计划赞助的前瞻性临床试验的随访结果

Shaw, Bronwen E; Jimenez-Jimenez, Antonio Martin; Burns, Linda J; Logan, Brent R; Khimani, Farhad; Shaffer, Brian C; Shah, Nirav N; Mussetter, Alisha; Tang, Xiao-Ying; McCarty, John M; Alavi, Asif; Farhadfar, Nosha; Jamieson, Katarzyna; Hardy, Nancy M; Choe, Hannah; Ambinder, Richard F; Anasetti, Claudio; Perales, Miguel-Angel; Spellman, Stephen R; Howard, Alan; Komanduri, Krishna V; Luznik, Leo; Norkin, Maxim; Pidala, Joseph A; Ratanatharathorn, Voravit; Confer, Dennis L; Devine, Steven M; Horowitz, Mary M; Bolaños-Meade, Javier

A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial

一项多中心 II 期、双盲、安慰剂对照试验,评估异基因移植后维持治疗伊沙佐米对高危多发性骨髓瘤的疗效:血液和骨髓移植临床试验网络 1302 试验结果

Bashir, Qaiser; Nishihori, Taiga; Pasquini, Marcelo C; Martens, Michael J; Wu, Juan; Alsina, Melissa; Anasetti, Claudio; Brunstein, Claudio; Dawson, Peter; Efebera, Yvonne; Gasparetto, Cristina; Geller, Nancy; Giralt, Sergio; Hall, Aric C; Koreth, John; McCarthy, Philip; Scott, Emma; Stadtmauer, Edward A; Vesole, David H; Hari, Parameswaran

Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting Cells

利用人工抗原呈递细胞进行 γδT 细胞大规模体外扩增

Justin C Boucher, Bin Yu, Gongbo Li, Bishwas Shrestha, David Sallman, Ana Marie Landin, Cheryl Cox, Kumar Karyampudi, Claudio Anasetti, Marco L Davila, Nelli Bejanyan

Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair

双重JAK2/Aurora激酶A抑制可通过同种异体失活和ILC2介导的组织修复来预防人皮肤移植排斥反应。

Walton, Kelly; Walker, Kirsti; Riddle, Megan; Koehn, Brent H; Reff, Jordan; Sagatys, Elizabeth M; Linden, Michael A; Pidala, Joseph; Kim, Jongphil; Lee, Marie C; Kiluk, John V; Hui, Jane Yuet Ching; Yun, Sang Y; Xing, Yan; Stefanski, Heather; Lawrence, Harshani R; Lawrence, Nicholas J; Tolar, Jakub; Anasetti, Claudio; Blazar, Bruce R; Sebti, Said M; Betts, Brian C

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

一项评估奥法妥木单抗联合泼尼松作为慢性移植物抗宿主病初始治疗方案的II期多中心试验

Lazaryan, Aleksandr; Lee, Stephanie; Arora, Mukta; Kim, Jongphil; Betts, Brian Christopher; Khimani, Farhad; Nishihori, Taiga; Bejanyan, Nelli; Liu, Hien; Kharfan-Dabaja, Mohamed A; Locke, Frederick L; Gonzalez, Rebecca; Jain, Michael D; Davila, Marco L; Perez, Lia Elena; Mishra, Asmita; Perez Perez, Ariel; Balke, Karlie; Ayala, Ernesto; Ochoa, Leonel; Castaneda Puglianini, Omar; Faramand, Rawan; Alsina, Melissa; Elmariah, Hany; Nieder, Michael L; Fernandez, Hugo; Anasetti, Claudio; Pidala, Joseph A

National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide

由美国国家骨髓捐献者计划赞助的多中心 II 期临床试验,研究 HLA 不匹配无关供者骨髓移植后使用环磷酰胺的疗效。

Shaw, Bronwen E; Jimenez-Jimenez, Antonio Martin; Burns, Linda J; Logan, Brent R; Khimani, Farhad; Shaffer, Brian C; Shah, Nirav N; Mussetter, Alisha; Tang, Xiao-Ying; McCarty, John M; Alavi, Asif; Farhadfar, Nosha; Jamieson, Katarzyna; Hardy, Nancy M; Choe, Hannah; Ambinder, Richard F; Anasetti, Claudio; Perales, Miguel-Angel; Spellman, Stephen R; Howard, Alan; Komanduri, Krishna V; Luznik, Leo; Norkin, Maxim; Pidala, Joseph A; Ratanatharathorn, Voravit; Confer, Dennis L; Devine, Steven M; Horowitz, Mary M; Bolaños-Meade, Javier

Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma

肿瘤干扰素信号传导和抑制性髓系细胞与大B细胞淋巴瘤中CAR-T细胞治疗失败相关。

Jain, Michael D; Zhao, Hua; Wang, Xuefeng; Atkins, Reginald; Menges, Meghan; Reid, Kayla; Spitler, Kristen; Faramand, Rawan; Bachmeier, Christina; Dean, Erin A; Cao, Biwei; Chavez, Julio C; Shah, Bijal; Lazaryan, Aleksandr; Nishihori, Taiga; Hussaini, Mohammed; Gonzalez, Ricardo J; Mullinax, John E; Rodriguez, Paulo C; Conejo-Garcia, Jose R; Anasetti, Claudio; Davila, Marco L; Locke, Frederick L